S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
$15.25
$15.23
$4.81
$15.37
$753.61M-0.06974,748 shs600 shs
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
$9.09
$9.06
$4.01
$9.10
$1.20B0.834.50 million shsN/A
DocGo Inc. stock logo
DCGO
DocGo
$3.57
+4.4%
$3.73
$2.78
$10.82
$371.89M0.911.55 million shs823,902 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
0.00%0.00%0.00%0.00%+77.54%
DocGo Inc. stock logo
DCGO
DocGo
+1.79%+1.94%-16.38%+8.57%-57.04%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
4.5274 of 5 stars
4.51.00.00.01.73.34.4

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/AN/AN/AN/A
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
2.00
HoldN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
3.00
Buy$10.83203.45% Upside

Current Analyst Ratings

Latest DCGO, AERI, and CTIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/11/2024
DocGo Inc. stock logo
DCGO
DocGo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $9.00
4/10/2024
DocGo Inc. stock logo
DCGO
DocGo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $8.00
4/10/2024
DocGo Inc. stock logo
DCGO
DocGo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $11.00
2/29/2024
DocGo Inc. stock logo
DCGO
DocGo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$13.00 ➝ $11.00
2/29/2024
DocGo Inc. stock logo
DCGO
DocGo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $10.00
2/29/2024
DocGo Inc. stock logo
DCGO
DocGo
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
2/23/2024
DocGo Inc. stock logo
DCGO
DocGo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $11.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
$194.13M3.88N/AN/A($3.32) per share-4.59
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
$53M22.62N/AN/A($0.14) per share-64.93
DocGo Inc. stock logo
DCGO
DocGo
$624.29M0.60$0.23 per share15.78$2.93 per share1.22

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
-$74.81M-$0.77N/AN/AN/A-17.09%N/A-2.00%N/A
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
-$92.99M-$0.58N/A26.74N/A-91.38%N/A-55.82%N/A
DocGo Inc. stock logo
DCGO
DocGo
$6.86M$0.0751.008.110.341.10%2.01%1.37%5/13/2024 (Estimated)

Latest DCGO, AERI, and CTIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/28/2024Q4 2023
DocGo Inc. stock logo
DCGO
DocGo
$0.13$0.06-$0.07$0.05$195.48 million$199.25 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/AN/AN/AN/AN/A
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
N/A
2.27
1.92
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
N/A
1.27
1.26
DocGo Inc. stock logo
DCGO
DocGo
N/A
1.99
1.99

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
95.94%
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
91.45%
DocGo Inc. stock logo
DCGO
DocGo
56.44%

Insider Ownership

CompanyInsider Ownership
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
4.44%
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
7.61%
DocGo Inc. stock logo
DCGO
DocGo
13.78%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aerie Pharmaceuticals, Inc. stock logo
AERI
Aerie Pharmaceuticals
37649.42 million47.22 millionOptionable
CTI BioPharma Corp. stock logo
CTIC
CTI BioPharma
127131.88 million121.84 millionOptionable
DocGo Inc. stock logo
DCGO
DocGo
4,164104.17 million89.82 millionOptionable

DCGO, AERI, and CTIC Headlines

SourceHeadline
DocGo Inc. (NASDAQ:DCGO) Given Average Rating of "Buy" by AnalystsDocGo Inc. (NASDAQ:DCGO) Given Average Rating of "Buy" by Analysts
marketbeat.com - April 19 at 6:14 AM
Traders Buy High Volume of Put Options on DocGo (NASDAQ:DCGO)Traders Buy High Volume of Put Options on DocGo (NASDAQ:DCGO)
americanbankingnews.com - April 19 at 1:38 AM
Investors Buy Large Volume of Put Options on DocGo (NASDAQ:DCGO)Investors Buy Large Volume of Put Options on DocGo (NASDAQ:DCGO)
marketbeat.com - April 18 at 11:42 AM
DocGo Inc. (NASDAQ:DCGO) Short Interest Up 5.9% in MarchDocGo Inc. (NASDAQ:DCGO) Short Interest Up 5.9% in March
americanbankingnews.com - April 18 at 5:10 AM
DocGo (DCGO) Price Target Decreased by 7.98% to 10.08DocGo (DCGO) Price Target Decreased by 7.98% to 10.08
msn.com - April 17 at 6:19 PM
DocGo Inc. (NASDAQ:DCGO) Sees Significant Growth in Short InterestDocGo Inc. (NASDAQ:DCGO) Sees Significant Growth in Short Interest
marketbeat.com - April 16 at 1:40 PM
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 15 at 3:00 AM
WCM Investment Management LLC Purchases 347,984 Shares of DocGo Inc. (NASDAQ:DCGO)WCM Investment Management LLC Purchases 347,984 Shares of DocGo Inc. (NASDAQ:DCGO)
marketbeat.com - April 14 at 10:44 AM
Canaccord Genuity Group Lowers DocGo (NASDAQ:DCGO) Price Target to $9.00Canaccord Genuity Group Lowers DocGo (NASDAQ:DCGO) Price Target to $9.00
americanbankingnews.com - April 13 at 5:26 AM
Q2 2024 Earnings Estimate for DocGo Inc. Issued By Northland Capmk (NASDAQ:DCGO)Q2 2024 Earnings Estimate for DocGo Inc. Issued By Northland Capmk (NASDAQ:DCGO)
americanbankingnews.com - April 13 at 2:00 AM
Stifel cuts DocGo stock target, maintains buy amid contract shiftStifel cuts DocGo stock target, maintains buy amid contract shift
investing.com - April 12 at 10:26 AM
P.A.W. Capital Corp Increases Position in DocGo Inc. (NASDAQ:DCGO)P.A.W. Capital Corp Increases Position in DocGo Inc. (NASDAQ:DCGO)
marketbeat.com - April 12 at 7:55 AM
DocGo Inc. Forecasted to Earn Q2 2024 Earnings of $0.06 Per Share (NASDAQ:DCGO)DocGo Inc. Forecasted to Earn Q2 2024 Earnings of $0.06 Per Share (NASDAQ:DCGO)
marketbeat.com - April 12 at 6:24 AM
FY2024 Earnings Estimate for DocGo Inc. Issued By Northland Capmk (NASDAQ:DCGO)FY2024 Earnings Estimate for DocGo Inc. Issued By Northland Capmk (NASDAQ:DCGO)
americanbankingnews.com - April 12 at 1:52 AM
Peeling Back The Layers: Exploring DocGo Through Analyst InsightsPeeling Back The Layers: Exploring DocGo Through Analyst Insights
markets.businessinsider.com - April 11 at 1:05 PM
DocGo (NASDAQ:DCGO) Price Target Cut to $9.00 by Analysts at Canaccord Genuity GroupDocGo (NASDAQ:DCGO) Price Target Cut to $9.00 by Analysts at Canaccord Genuity Group
marketbeat.com - April 11 at 8:25 AM
Brokers Issue Forecasts for DocGo Inc.s FY2024 Earnings (NASDAQ:DCGO)Brokers Issue Forecasts for DocGo Inc.'s FY2024 Earnings (NASDAQ:DCGO)
marketbeat.com - April 11 at 7:42 AM
BTIG Research Trims DocGo (NASDAQ:DCGO) Target Price to $11.00BTIG Research Trims DocGo (NASDAQ:DCGO) Target Price to $11.00
americanbankingnews.com - April 11 at 5:12 AM
DocGo (NASDAQ:DCGO) PT Lowered to $8.00DocGo (NASDAQ:DCGO) PT Lowered to $8.00
americanbankingnews.com - April 11 at 4:28 AM
New York City to end contract with DocGoNew York City to end contract with DocGo
modernhealthcare.com - April 10 at 8:44 PM
DocGo Signs Extension and Begins Planned Transition of Asylum Seeker Contract with New York City HPDDocGo Signs Extension and Begins Planned Transition of Asylum Seeker Contract with New York City HPD
businesswire.com - April 10 at 2:13 PM
DocGo slips as New York City moves to end migrant contractDocGo slips as New York City moves to end migrant contract
msn.com - April 10 at 10:43 AM
Stifel Nicolaus Trims DocGo (NASDAQ:DCGO) Target Price to $8.00Stifel Nicolaus Trims DocGo (NASDAQ:DCGO) Target Price to $8.00
marketbeat.com - April 10 at 8:46 AM
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the FirmONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 8 at 7:00 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aerie Pharmaceuticals logo

Aerie Pharmaceuticals

NASDAQ:AERI
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
CTI BioPharma logo

CTI BioPharma

NASDAQ:CTIC
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTI BioPharma Corp. has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. and S*BIO Pte Ltd. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
DocGo logo

DocGo

NASDAQ:DCGO
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.